| Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment (NCT04883125) | Mansoura University | 2018-01-01 |
| Treatment of Gingival Recession Using Mesenchymal Stem Cells (NCT04434794) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2018-01-01 |
| Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma (NCT03100877) | City of Hope Medical Center | 2018-01-01 |
| The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments (NCT05145686) | Ege University | 2018-01-01 |
| Autologous Platelet-rich Plasma for Clomiphene Citrate-induced Thin Endometrium (NCT03770026) | Benha University | 2018-01-01 |
| Apatinib in the Treatment of Metastatic Colorectal Cancer (NCT03403452) | Fudan University | 2018-01-01 |
| The Effect of Vitamin C on Quality of Life of Terminal Cancer Patients (NCT03224572) | National Taiwan University Hospital | 2018-01-01 |
| Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD (NCT03994640) | Medical University of Silesia | 2018-01-01 |
| Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn (NCT03237442) | Guangzhou Saliai Stem Cell Science and Technology Co. Ltd. | 2018-01-01 |
| Haploidentical Donor vs mMUD in Hematological Malignancies (NCT03275636) | DKMS gemeinnützige GmbH | 2018-01-01 |
| Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions (NCT03233412) | Barretos Cancer Hospital | 2018-01-01 |
| Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease (NCT02636283) | University of Minnesota | 2017-12-31 |
| AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA (NCT03191240) | Asan Medical Center | 2017-12-31 |
| A Study in MPS VI to Assess Safety and Efficacy of Odiparcil (NCT03370653) | Inventiva Pharma | 2017-12-30 |
| Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies (NCT03098355) | Zhujiang Hospital | 2017-12-30 |
| 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) (NCT03367676) | Ruijin Hospital | 2017-12-30 |
| Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma (NCT03371459) | AstraZeneca | 2017-12-29 |
| A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine (NCT03369808) | Shanghai Institute Of Biological Products | 2017-12-29 |
| Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures (NCT03336242) | Radius Pharmaceuticals, Inc. | 2017-12-29 |
| Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis (NCT03155932) | Arena Pharmaceuticals | 2017-12-29 |
| Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads (NCT03023904) | Vanderbilt-Ingram Cancer Center | 2017-12-29 |
| Her2-BATS and Pembrolizumab in Metastatic Breast Cancer (NCT03272334) | University of Virginia | 2017-12-29 |
| A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis (NCT05747508) | Bellerophon | 2017-12-29 |
| Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer (NCT03087071) | M.D. Anderson Cancer Center | 2017-12-29 |
| Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease (NCT03402659) | EIP Pharma Inc | 2017-12-29 |
| Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL (NCT03249870) | Versailles Hospital | 2017-12-28 |
| CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) (NCT03328078) | Curis, Inc. | 2017-12-28 |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors (NCT02684058) | Novartis Pharmaceuticals | 2017-12-28 |
| Study of Anti-Malarials in Incomplete Lupus Erythematosus (NCT03030118) | Milton S. Hershey Medical Center | 2017-12-28 |
| A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression (NCT03460756) | Marinus Pharmaceuticals | 2017-12-28 |
| A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer (NCT03507166) | RemeGen Co., Ltd. | 2017-12-28 |
| Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic （GEP） Neuroendocrine Carcinoma （NEC, WHO Grade 3） as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes (NCT03147404) | Samsung Medical Center | 2017-12-28 |
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy (NCT03387098) | ImmunityBio, Inc. | 2017-12-28 |
| Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine. (NCT03902054) | Jiangsu Province Centers for Disease Control and Prevention | 2017-12-28 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 (NCT03378648) | Chiesi Farmaceutici S.p.A. | 2017-12-28 |
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (NCT03333616) | Dana-Farber Cancer Institute | 2017-12-28 |
| Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy (NCT03352076) | Viramal Limited | 2017-12-28 |
| A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) (NCT03337698) | Hoffmann-La Roche | 2017-12-27 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (NCT03394924) | Enanta Pharmaceuticals, Inc | 2017-12-27 |
| Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer (NCT03244956) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-12-27 |
| A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) (NCT03350165) | Kowa Company, Ltd. | 2017-12-27 |
| Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer (NCT03196388) | Fundación Canaria Instituto de Investigación Sanitaria de Canarias | 2017-12-27 |
| A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy (NCT03153293) | Huazhong University of Science and Technology | 2017-12-27 |
| OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia (NCT03390296) | M.D. Anderson Cancer Center | 2017-12-27 |
| Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy (NCT03113422) | PrECOG, LLC. | 2017-12-27 |
| A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer (NCT03331562) | Translational Genomics Research Institute | 2017-12-27 |
| A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis (NCT03358030) | Ionis Pharmaceuticals, Inc. | 2017-12-26 |
| A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX (NCT03366337) | Biogen | 2017-12-26 |
| Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients (NCT03430856) | Biocon Limited | 2017-12-26 |
| Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib (NCT03163992) | Samsung Medical Center | 2017-12-26 |
| A Randomized Controlled Trial of Mecobalamin Injection and Tablet Treatment Efficacy on Mild to Moderate Diabetic Peripheral Neuropathy (NCT04372316) | Peking University Third Hospital | 2017-12-25 |
| Laparoscopic Guided Transversus Abdominis Plane Block for Postoperative Analgesia After Pediatric Laparoscopic Surgery. (NCT03388671) | Assiut University | 2017-12-25 |
| Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH). (NCT03338998) | Novartis Pharmaceuticals | 2017-12-24 |
| Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL (NCT03373071) | Bambino Gesù Hospital and Research Institute | 2017-12-23 |
| Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection. (NCT03212716) | University Hospital, Lille | 2017-12-23 |
| The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation (NCT03339401) | Jazz Pharmaceuticals | 2017-12-22 |
| A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) (NCT03285178) | Cyclerion Therapeutics | 2017-12-22 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis (NCT03451045) | Corbus Pharmaceuticals Inc. | 2017-12-22 |
| Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity (NCT03738514) | Government Dental College and Research Institute, Bangalore | 2017-12-22 |
| A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer (NCT03280563) | Hoffmann-La Roche | 2017-12-22 |
| Breast Cancer Study of Preoperative Pembrolizumab + Radiation (NCT03366844) | Stephen Shiao | 2017-12-22 |
| Multicentric Randomised Trial for Resectable Gastric Cancer (NCT02931890) | The Netherlands Cancer Institute | 2017-12-21 |
| Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies (NCT03317496) | Pfizer | 2017-12-21 |
| JBT-101 in Systemic Lupus Erythematosus (SLE) (NCT03093402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-12-21 |
| Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT03373019) | Fudan University | 2017-12-21 |
| Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer (NCT03371979) | Aeglea Biotherapeutics | 2017-12-21 |
| Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis (NCT03404570) | Atacama Therapeutics | 2017-12-21 |
| Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI) (NCT03298048) | The University of Texas Health Science Center, Houston | 2017-12-21 |
| Pre-operative Immunotherapy Combination Strategies in Breast Cancer (NCT03395899) | Queen Mary University of London | 2017-12-21 |
| A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia (NCT03319953) | Neurocrine Biosciences | 2017-12-21 |
| Prednisolone in Early Diffuse Systemic Sclerosis (NCT03708718) | Prof. Ariane herrick | 2017-12-21 |
| Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) (NCT03360747) | Akcea Therapeutics | 2017-12-21 |
| Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease (NCT03371355) | Akcea Therapeutics | 2017-12-21 |
| Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma (NCT03275376) | Taichung Veterans General Hospital | 2017-12-21 |
| A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients (NCT03145961) | Institute of Cancer Research, United Kingdom | 2017-12-21 |
| Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT (NCT03389035) | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 2017-12-20 |
| Laminaria and Misoprostol Before Operative Hysteroscopy (NCT03388827) | Zagazig University | 2017-12-20 |
| Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT) (NCT03241927) | Nina Bhardwaj | 2017-12-20 |
| Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Postoperative Pain Following Total Hip Arthroplasty. (NCT03347266) | Vivozon, Inc. | 2017-12-20 |
| Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer (NCT03373708) | Zhiyong Yu | 2017-12-20 |
| FLOTOR Pilot Study (NCT03292757) | Oxford University Hospitals NHS Trust | 2017-12-20 |
| Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (NCT03345004) | Diamyd Medical AB | 2017-12-20 |
| Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03370276) | H. Lee Moffitt Cancer Center and Research Institute | 2017-12-20 |
| Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer (NCT03366766) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-12-20 |
| Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy (NCT03581773) | Niels Fristrup | 2017-12-20 |
| HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer (NCT03553602) | Loyola University | 2017-12-20 |
| Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis (NCT03287414) | Novartis Pharmaceuticals | 2017-12-20 |
| Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity (NCT03741309) | Government Dental College and Research Institute, Bangalore | 2017-12-20 |
| Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma (NCT03399552) | Memorial Sloan Kettering Cancer Center | 2017-12-20 |
| Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma (NCT03347617) | OHSU Knight Cancer Institute | 2017-12-20 |
| Antimicrobial Effect OF Propolis Administrated Through Two Different Vehicles In High Caries Risk Children (NCT03812315) | Nourhan M.Aly | 2017-12-20 |
| Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures (NCT03166189) | D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology | 2017-12-20 |
| Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. (NCT03269695) | Pfizer | 2017-12-20 |
| Vitamin C and Septic Shock (NCT03338569) | University of Minnesota | 2017-12-20 |
| Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC (NCT03164772) | Ludwig Institute for Cancer Research | 2017-12-20 |
| A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies (NCT03310619) | Celgene | 2017-12-20 |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast (NCT03304080) | Icahn School of Medicine at Mount Sinai | 2017-12-20 |
| Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy (NCT03382743) | Kasr El Aini Hospital | 2017-12-20 |
| Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT02844582) | University of California, Davis | 2017-12-20 |
| Topical Capsaicin for Cyclical Vomiting (NCT03223350) | Henry Ford Health System | 2017-12-20 |